GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31 | 232 | 1,068 | 191 | 1,591 |
| Receivables | 226 | 267 | 885 | 145 | 832 |
| Inventories | 63 | 235 | 506 | 258 | 646 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 11 |
| Other current assets | 0 | 0 | 0 | 1,914 | 0 |
| TOTAL | $335 | $820 | $2,568 | $2,627 | $3,177 |
| Non-Current Assets | |||||
| PPE Net | 30 | 46 | 153 | 45 | 190 |
| Intangibles | 476 | 521 | 2,039 | 549 | 2,170 |
| Other Non-Current Assets | 0 | 0 | 0 | 1,636 | 0 |
| TOTAL | $506 | $567 | $2,192 | $2,230 | $2,360 |
| Total Assets | $841 | $1,387 | $4,760 | $4,857 | $5,537 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,143 | 1,074 | 966 | 797 | N/A |
| Accounts payable and accrued liabilities | 959 | 1,343 | 1,208 | 667 | 977 |
| Accrued Expenses | 1,139 | 1,069 | 1,135 | 993 | 1,397 |
| Other current liabilities | 164 | 668 | 668 | 1,612 | 1,100 |
| TOTAL | $4,405 | $4,154 | $4,048 | $4,069 | $3,474 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 628 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 25 | 0 |
| TOTAL | $N/A | $N/A | $25 | $25 | $653 |
| Total Liabilities | $4,405 | $4,154 | $4,073 | $4,094 | $4,127 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,851 | 46,851 | 46,851 | 46,851 | 46,611 |
| Common Shares | 47 | 47 | 47 | 47 | 47 |
| Retained earnings | -74,272 | -73,475 | -70,942 | -69,848 | -70,128 |
| Other shareholders' equity | -416 | -416 | 505 | -416 | 552 |
| TOTAL | $-3,564 | $-2,767 | $687 | $763 | $1,410 |
| Total Liabilities And Equity | $841 | $1,387 | $4,760 | $4,857 | $5,537 |